Highland Capital Management, LLC Merck & Co., Inc. Transaction History

Highland Capital Management, LLC

  • $1.73 Billion
  • Q1 2024

A detailed history of Highland Capital Management, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Highland Capital Management, LLC holds 287,950 shares of MRK stock, worth $36.8 Million. This represents 2.19% of its overall portfolio holdings.

Number of Shares
287,950
Previous 290,036 0.72%
Holding current value
$36.8 Million
Previous $31.6 Million 20.17%
% of portfolio
2.19%
Previous 1.97%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024
SELL
$113.24 - $131.95 $236,218 - $275,247
-2,086 Reduced 0.72%
287,950 $38 Million
Q4 2023

Jan 17, 2024
SELL
$100.18 - $109.02 $224,503 - $244,313
-2,241 Reduced 0.77%
290,036 $31.6 Million
Q3 2023

Nov 14, 2023
BUY
$102.95 - $114.33 $1.45 Million - $1.61 Million
14,041 Added 5.05%
292,277 $30.1 Million
Q2 2023

Aug 09, 2023
SELL
$108.61 - $118.38 $309,864 - $337,738
-2,853 Reduced 1.01%
278,236 $32.1 Million
Q1 2023

May 11, 2023
BUY
$102.94 - $114.86 $28.9 Million - $32.3 Million
281,089 New
281,089 $29.9 Million
Q4 2022

Feb 07, 2023
SELL
$87.44 - $112.11 $2.35 Million - $3.01 Million
-26,867 Reduced 7.15%
348,644 $38.7 Million
Q3 2022

Nov 09, 2022
BUY
$84.53 - $94.96 $1.48 Million - $1.66 Million
17,487 Added 4.88%
375,511 $32.3 Million
Q2 2022

Jul 14, 2022
SELL
$83.49 - $94.64 $1.26 Million - $1.43 Million
-15,071 Reduced 4.04%
358,024 $32.6 Million
Q1 2022

Apr 19, 2022
SELL
$73.51 - $82.4 $176,424 - $197,760
-2,400 Reduced 0.64%
373,095 $30.6 Million
Q4 2021

Jan 28, 2022
SELL
$72.28 - $90.54 $278,928 - $349,393
-3,859 Reduced 1.02%
375,495 $28.8 Million
Q3 2021

Oct 25, 2021
SELL
$71.68 - $78.83 $32,757 - $36,025
-457 Reduced 0.12%
379,354 $28.5 Million
Q2 2021

Jul 30, 2021
SELL
$70.31 - $77.77 $2.42 Million - $2.68 Million
-34,416 Reduced 8.31%
379,811 $29.5 Million
Q1 2021

Apr 27, 2021
SELL
$68.86 - $81.11 $319,166 - $375,944
-4,635 Reduced 1.11%
414,227 $31.9 Million
Q4 2020

Jan 21, 2021
SELL
$71.77 - $79.65 $538,131 - $597,215
-7,498 Reduced 1.76%
418,862 $34.3 Million
Q3 2020

Oct 16, 2020
SELL
$73.18 - $82.95 $87,889 - $99,622
-1,201 Reduced 0.28%
426,360 $35.4 Million
Q2 2020

Jul 22, 2020
SELL
$70.42 - $80.13 $4.12 Million - $4.69 Million
-58,474 Reduced 12.03%
427,561 $33.1 Million
Q1 2020

May 05, 2020
SELL
$63.36 - $87.82 $242,732 - $336,438
-3,831 Reduced 0.78%
486,035 $37.4 Million
Q4 2019

Feb 05, 2020
SELL
$77.58 - $87.54 $39.4 Million - $44.5 Million
-508,038 Closed
0 $0
Q3 2019

Nov 20, 2019
BUY
$76.08 - $82.93 $3.13 Million - $3.41 Million
41,126 Added 8.81%
508,038 $42.8 Million
Q2 2019

Jul 29, 2019
SELL
$69.84 - $81.59 $164,193 - $191,818
-2,351 Reduced 0.5%
466,912 $39.2 Million
Q1 2019

Apr 18, 2019
SELL
$69.58 - $79.36 $248,470 - $283,394
-3,571 Reduced 0.76%
469,263 $39 Million
Q4 2018

Jan 16, 2019
SELL
$65.24 - $75.71 $5.54 Million - $6.43 Million
-84,876 Reduced 15.22%
472,834 $36.1 Million
Q3 2018

Oct 17, 2018
SELL
$57.69 - $67.84 $94,957 - $111,664
-1,646 Reduced 0.29%
557,710 $39.6 Million
Q2 2018

Jul 18, 2018
SELL
$50.83 - $59.72 $1.64 Million - $1.92 Million
-32,223 Reduced 5.45%
559,356 $34 Million
Q1 2018

Apr 16, 2018
SELL
$50.96 - $59.23 $441,466 - $513,109
-8,663 Reduced 1.44%
591,579 $32.2 Million
Q4 2017

Jan 26, 2018
SELL
$51.62 - $61.64 $143,658 - $171,544
-2,783 Reduced 0.46%
600,242 $33.8 Million
Q3 2017

Oct 10, 2017
BUY
$58.67 - $63.13 $35.4 Million - $38.1 Million
603,025
603,025 $38.6 Million

Others Institutions Holding MRK

# of Institutions
3,771
Shares Held
1.87B
Call Options Held
17.3M
Put Options Held
14.8M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $324B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Highland Capital Management, LLC Portfolio

Follow Highland Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highland Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email